WD-40 stock
WDFCNASDAQWD-40 Company, Basic MaterialsISIN US9292361071
73Score 73 out of 100, Strong
Price and trend
66 / 100
Price history
+9.8% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 0.2% above it.
Since September 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Normal: the price is neither overheated nor sold off (RSI 56).
The price is 17% below its 52-week high. Largest decline in 20 years: 55% (February 2021 to October 2022).
Chart figures for advanced users
- SMA 50$206.35
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$219.94
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)56
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$187.52
- The lowest closing price of the last twelve months.
- Resistance$264.91
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- WD-40 Company belongs to the Chemicals (Specialty) industry (United States) and, with a market value of $2.95B, is number 78 of 108 companies in its industry on MEQIRI.
- In fiscal 2026 it reported revenue of $687.99M (up 11% year on year) and earnings of $82.35M (down 9.5%).
- For fiscal 2027, analysts expect on average revenue of $727.76M (up 5.8%) and adjusted earnings per share of $6.54 (up 6%).
Show more
- MEQIRI Score 73 out of 100 (Strong): rank 55 of 467 in Basic Materials, median 58.
- The P/E is 36 (Chemicals (Specialty) median 24.4, own median of recent years 41.5).
- Our model puts fair value at $133.82, with the price 64% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Reliable dividendNo dividend cut for 24 years.Capital allocation 85
- High return on capitalReturn on invested capital 27.7% in fiscal 2026, Chemicals (Specialty) median 6.2%.Profitability 85
- Consistently profitableProfit in all 10 fiscal years from 2017 to 2026.Fundamentals 96
Weaknesses
- Above fair valuePrice 64% above the fair value of $133.82.Valuation 24
Its standout strengths are fundamentals and stability, while valuation holds the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Fundamentals are strong, with stable profits and strong cash generation.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk medium
How well MEQIRI warnsIn the middle among smaller stocks.
From 2016 to 2025, 20 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- cyclical sector (energy or materials), as a group, crashed more often in the backtest
What lowers it
- solid fundamentals
Valuation
Valuation signal
Significantly overvaluedClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $102.94 and expensive above $191.17 (uncertainty medium, based on the price swings of the past year).
The two parts of the fair value come to $118.59 (cash-flow model) and $149.05 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is above both.
Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $124.24, at 7.8% it would be $148.16.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (24.4).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In fiscal 2026, revenue rose 11% on the prior year. Revenue has grown solidly since 2007, at about 4% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2026: gross 55%, operating 16%, net 12%.
Debt & balance sheet
latest quarterThe balance sheet is solid, with moderate debt and comfortable interest coverage.
Earnings
- Next earnings
- 14 Jan 2027in 63 days
- Last reported
- 21 Oct 2026EPS reported $1.06 (expected $1.13)below expectations
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- $6.54+1.0%
- Revenue
- $727.76M+0.1%
- Earnings per share
- $7.09−1.7%
- Revenue
- $765.93M−1.1%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook confirmed
Share price after the results: +7.4%Guidance ranges narrowed: net sales of $652 million to $667 million (up 6% to 9%), gross margin of 54% to 55.5% and non-GAAP operating income of $107 million to $113 million.
“For fiscal year 26, we now expect net sales in constant currency to be between $652 million and $667 million representing growth of 6% to 9%.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 9 Jul 2026 (fiscal Q3 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
No open-market purchases in the last 6 months. One insider sold, $117,063 in total.
Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at WD-40
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
467 rated companies in Basic Materials
- This company
- 73
- Sector median
- 58
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals (Specialty)
The next larger and next smaller companies by market value
- HEXPOLHPOL-B.ST $3.31B68
- Azelis GroupAZE.BR $3.18B59
- HawkinsHWKN $3.16B69
- CalumetCLMT $3.15B47
- H.B. FullerFUL $2.73B53
- Quaker HoughtonKWR $2.68B54
- IngevityNGVT $2.14B60
- ChemoursCC $2.07B32
ETFs that hold WD-40
Held by 13 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| iShares S&P SmallCap 600 UCITS ETFIUS3 | 0.18% | 0.30% | €2.28B |
| L&G Russell 2000 US Small Cap Quality UCITS ETFETLZ | 0.13% | 0.30% | €185.82M |
| State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)ZPRR | 0.10% | 0.30% | €4.22B |
Show 5 more
| Xtrackers Russell 2000 UCITS ETF 1CXRS2 | 0.10% | 0.30% | €2.17B |
| iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETFSXRG | 0.05% | 0.43% | €2.48B |
| State Street SPDR MSCI World Small Cap UCITS ETF (Acc)ZPRS | 0.03% | 0.45% | €1.53B |
| State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETFZPRV | 0.02% | 0.30% | €944.34M |
| iShares MSCI World Small Cap CTB Enhanced ESG UCITS ETFCBUG | 0.01% | 0.35% | €434.1M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Aug 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 23 Oct 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.